Skip to menu Skip to content Skip to footer
Professor Haitham Tuffaha
Professor

Haitham Tuffaha

Email: 
Phone: 
+61 7 334 61156

Overview

Background

I am the Interim Director at The University of Queensland’s Centre for the Business and Economics of Health (CBEH). I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical Benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $40 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology Group, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.

Availability

Professor Haitham Tuffaha is:
Available for supervision
Media expert

Research interests

  • Economic Evaluation of Healthcare Interventions

  • Health Technology Assessment

  • Value-Based Health Care

  • Cancer Economics

  • Medications use and safety

Research impacts

My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.

I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.

Works

Search Professor Haitham Tuffaha’s works on UQ eSpace

125 works between 2005 and 2024

1 - 20 of 125 works

2024

Journal Article

Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review

Pak, Anton, O'Grady, Madeline, Holtmann, Gerald, Shah, Ayesha and Tuffaha, Haitham (2024). Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review. PharmacoEconomics. doi: 10.1007/s40273-024-01455-y

Economic evaluations of non-pharmacological interventions for treating disorders of gut-brain interaction: a scoping review

2024

Journal Article

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Other Outputs

MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)

2024

Conference Publication

EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis

Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551

EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis

2024

Journal Article

Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol

Ferris, Laura J., Ludlow, Kristiana, Walker, Nicole, Georgiou, Andrew, Henry, Julie D., Lopez Silva, Claudia, Ha, Diep H., Stormon, Nicole, Walsh, Laurence J., Ivanovski, Saso, Sexton, Christopher, Silveira Schuch, Helena, Tuffaha, Haitham, Zamora, Angelique, Pritchard, Lyndal and Do, Loc G. (2024). Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol. Healthcare, 12 (19) 1953, 1-10. doi: 10.3390/healthcare12191953

Modified Oral Health Assessment Tool (M-OHAT) for residential aged care: A co-design protocol

2024

Other Outputs

MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation

2024

Other Outputs

MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia

Hettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia

2024

Journal Article

A preference-based value framework to assess healthcare provision in an oil and gas industry

Pak, Anton, Pols, Thomas, Kondalsamy-Chennakesavan, Srinivas, McGrail, Matthew, Gurney, Tiana, Fox, Jordan L. and Tuffaha, Haitham (2024). A preference-based value framework to assess healthcare provision in an oil and gas industry. Australian Health Review, 48 (5), 524-529. doi: 10.1071/ah24111

A preference-based value framework to assess healthcare provision in an oil and gas industry

2024

Journal Article

Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot

Heneka, Nicole, Chambers, Suzanne K., Schaefer, Isabelle, Carmont, Kelly, Parcell, Melinda, Wallis, Shannon, Walker, Stephen, Tuffaha, Haitham, Steele, Michael and Dunn, Jeff (2024). Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. Australian Journal of Rural Health, 32 (4), 815-826. doi: 10.1111/ajr.13149

Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot

2024

Journal Article

The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer

Teppala, Srinivas, Scuffham, Paul A. and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer. International Journal of Technology Assessment in Health Care, 40 (1) e14, e14. doi: 10.1017/s0266462324000011

The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer

2024

Journal Article

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)

Green, Anna, Newton, Robert U, Smith, David P, Tuffaha, Haitham, Galvão, Daniel A, Heathcote, Peter, Patel, Manish I, Christie, David, Egger, Sam, Sara, Sally AM, Heneka, Nicole, Chambers, Suzanne K and Dunn, Jeff (2024). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). BMJ Open, 14 (3) e084412, 1-9. doi: 10.1136/bmjopen-2024-084412

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study)

2024

Other Outputs

MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia.

MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation

2024

Book Chapter

The expected value of perfect or partial perfect information

Jackson, Christopher, Jalal, Hawre, Heath, Anna, Kunst, Natalia, Thom, Howard, Welton, Nicky J., Tuffaha, Haitham and Wilson, Edward C. F. (2024). The expected value of perfect or partial perfect information. Value of information for healthcare decision-making. (pp. 47-91) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-3

The expected value of perfect or partial perfect information

2024

Journal Article

Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India

Arora, Shiksha and Tuffaha, Haitham (2024). Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India. Asia-Pacific Journal of Clinical Oncology, 20 (1), 55-62. doi: 10.1111/ajco.13962

Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India

2024

Book Chapter

Value of information: success stories

Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-206) edited by Anna Heath, Natalia Kuns and Christopher Jackson. Boca Raton, FL, United States: Chapman and Hall/CRC. doi: 10.1201/9781003156109-6

Value of information: success stories

2024

Journal Article

Guidelines for genetic testing in prostate cancer: a scoping review

Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0

Guidelines for genetic testing in prostate cancer: a scoping review

2024

Book Chapter

Value of information: success stories

Kunst, Natalia, Wilson, Edward C. F., Tuffaha, Haitham, Jackson, Christopher, Welton, Nicky J., Jalal, Hawre and Alarid-Escudero, Fernando (2024). Value of information: success stories. Value of information for healthcare decision-making. (pp. 193-205) edited by Anna Heath, Natalia Kunst and Christopher Jackson. Boca Raton, FL, United States: Taylor and Francis. doi: 10.1201/9781003156109

Value of information: success stories

2023

Journal Article

Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals

Taylor, William J., Tuffaha, Haitham, Hawley, Carmel M., Peyton, Philip, Higgins, Alisa M., Scuffham, Paul A., Nemeh, Fiona, Balagurunathan, Anitha, Hansen, Paul, Jacques, Angela and Morton, Rachael L. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PLoS One, 18 (12) e0295304, 1-12. doi: 10.1371/journal.pone.0295304

Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals

2023

Other Outputs

Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment

Maguire, Angela M., Soole, Rebecca, Beilby, Hannah, Tabinga, Angeli, Barker, Natalie, Fear, Nicola T., Kenardy, Justin, Tuffaha, Haitham and Khoo, Andrew (2023). Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment. Canberra, ACT Australia: Commonwealth of Australia.

Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment

2023

Journal Article

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

Modi, Natansh D., Kichenadasse, Ganessan, Hoffmann, Tammy C., Haseloff, Mark, Logan, Jessica M., Veroniki, Areti A., Venchiarutti, Rebecca L., Smit, Amelia K., Tuffaha, Haitham, Jayasekara, Harindra, Manning-Bennet, Arkady, Morton, Erin, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J. and Hopkins, Ashley M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21 (1) 400, 400. doi: 10.1186/s12916-023-03113-0

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

Funding

Current funding

  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2029
    Paediatric Immune Cell Atlas for Immunotherapy Innovation (PICACHIU)
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2028
    Effectiveness of a Healthy Lifestyle and Resilience Program in New-Onset Rheumatoid Arthritis
    NHMRC MRFF Clinician Researchers Applied Research in Health
    Open grant
  • 2024 - 2025
    Value-based assessment and cost-effectiveness analysis of two models of exercise oncology implementation
    Exercise and Sports Science Australia Ltd
    Open grant
  • 2023 - 2028
    ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
    ARC Industrial Transformation Research Hubs
    Open grant
  • 2023 - 2027
    Implementing integrated psychological and physical care for Australians after road traffic injury
    NHMRC MRFF Clinician Researchers: Nurses, Midwives and Allied Health Grant
    Open grant
  • 2023 - 2026
    Oral Health in Aged Care: Addressing Oral Health Inequity and Unmet Dental Care Needs of Vulnerable Population
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2026
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2021 - 2026
    BALANCE: Promoting wellBeing in AdoLescent and young Adult cancer survivors
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2025
    Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes (NHMRC Partnership Projects administered by USQ)
    University of Southern Queensland
    Open grant
  • 2020 - 2025
    EnhAnCing treatment oUtcoMes after gynaEcological caNcer (ACUMEN): Using exercise to promote health after cancer therapy
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2017 - 2024
    ARC Training Centre for Innovation in Biomedical Imaging Technology
    ARC Industrial Transformation Training Centres
    Open grant

Past funding

  • 2023 - 2024
    Health economics analysis of animal plasma-derived antivenoms and antivenom distribution pathways for sub-Saharan Africa
    Global Snakebite Initiative USA Foundation
    Open grant
  • 2023
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study (RBWH Foundation Project Grant administered by Metro North Hospital)
    Metro North Hospital and Health Service
    Open grant
  • 2023 - 2024
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2023
    Financial Efficiency Evaluation of PCFAs Prostate Cancer Specialist Nursing Program
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2022 - 2023
    The Value of Genetic Testing for Prostate Cancer
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Efficacy and Effectiveness of Prophylactic fOam dressings in the prevention of saCral pressure injuries in at-risk hospitalised patients: The EEPOC Trial (NHMRC project grant administered by Griffith)
    Griffith University
    Open grant
  • 2022
    Cost-effectiveness analysis of lung cancer rehabilitation
    University of Melbourne
    Open grant
  • 2022
    Emerging and Adjunct treatments for PTSD and other mental health conditions affecting veterans: a rapid evidence assessment.
    Gallipoli Medical Research Foundation
    Open grant
  • 2021 - 2022
    Spillover Effects of Military Service on Health and Wellbeing in Veteran Families
    Gallipoli Medical Research Foundation
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2020
    Improving patient access to novel cancer drugs in Australia: striking the balance
    NHMRC Early Career Fellowships
    Open grant

Supervision

Availability

Professor Haitham Tuffaha is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program

    Principal Advisor

    Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds

  • Doctor Philosophy

    Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment

    Principal Advisor

    Other advisors: Professor Sandie McCarthy

  • Doctor Philosophy

    Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program

    Principal Advisor

    Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds

Completed supervision

Media

Enquiries

Contact Professor Haitham Tuffaha directly for media enquiries about:

  • Cancer Economics
  • Health Economics
  • Health Services Research

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au